Anti-TNF agents may also be an alternative to colchicine, especially in patients with FMF with predominant joint involvement (persistent peripheral arthritis or spondyloarthritis) or associated inflammatory bowel disease (Crohn’s disease) (35, 37, 39). The gene discussed is TNF; the disease is Crohn disease.